Biogen, Inc. (BIIB) Butterfly Trade Entry

TheOptionPlayer.com executed the Biogen (NasdaqGS: BIIB) short-term (16-day) option strategy The difference between funds paid out and received is a $2.25 per share debit maximum risk for this trade. The maximum profit is approximately $7.75 per share if Biogen stock moves higher prior to the option contract expiration date. See published trade https://www.theoptionplayer.com/biogen-biib-stock-presents-a-pre-earnings-buying-opportunity/ The information…